Risk communication during COVID-19
| dc.creator | Abrams, Elissa M. | |
| dc.creator | Greenhawt, Matthew | |
| dc.date.accessioned | 2020-05-07T17:05:24Z | |
| dc.date.available | 2020-05-07T17:05:24Z | |
| dc.date.issued | 2020-04 | |
| dc.description.abstract | Indisponível. | pt_BR |
| dc.identifier.citation | ABRAMS, E. M; GREENHAWT, M. Risk communication during COVID-19. The Journal of Allergy and Clinical Immunology: In Practice, [S.l.], Apr. 2020. No prelo. | pt_BR |
| dc.identifier.uri | https://repositorio.ufla.br/handle/1/40677 | |
| dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S2213219820303639 | pt_BR |
| dc.language | en_US | pt_BR |
| dc.publisher | Elsevier | pt_BR |
| dc.rights | openAccess | pt_BR |
| dc.source | The Journal of Allergy and Clinical Immunology: In Practice | pt_BR |
| dc.subject | COVID-19 | pt_BR |
| dc.subject | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | pt_BR |
| dc.subject | Risk communication | pt_BR |
| dc.subject | Health policy | pt_BR |
| dc.subject | Pandemic | pt_BR |
| dc.title | Risk communication during COVID-19 | pt_BR |
| dc.type | Artigo | pt_BR |
Arquivos
Licença do pacote
1 - 1 de 1
Carregando...
- Nome:
- license.txt
- Tamanho:
- 953 B
- Formato:
- Item-specific license agreed upon to submission
- Descrição:
